🇺🇸 FDA
Patent

US 12133890

Antigen-binding polypeptide targeting B7H3 and application thereof

granted A61KA61K2039/505A61K2239/13

Quick answer

US patent 12133890 (Antigen-binding polypeptide targeting B7H3 and application thereof) held by NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD.
Grant date
Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/505, A61K2239/13, A61K2239/31, A61K2239/38